The estimated cumulative risks of developing BC by age 50 years were 4% (95% CI = 3% to 6%) for carriers of pathogenic variants in RAD51C and 4% (95% CI = 2% to 5%) for RAD51D carriers [164]. The gene discussed is RAD51D; the disease is breast cancer.